Riley Exploration Permian borrows $130 million under Truist-led credit facility to refinance senior notes
Bitget2026/10/07 20:07Riley Exploration Permian drew USD 130 million under its Truist-led Credit Agreement on Oct. 5, 2026. Proceeds refinanced REP’s 10.50% Senior Unsecured Notes due 2028 via full voluntary prepayment of USD 130 million principal. Credit Agreement borrowings outstanding rose to USD 245 million; borrowing base USD 425 million; elected commitments USD 400 million. Facility pricing set at Term SOFR plus 2.75%-3.75% for SOFR loans; base rate plus 1.75%-2.75% for base-rate loans. Credit Agreement maturity extended to Dec. 13, 2028 following the notes repayment. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Riley Exploration Permian Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001001614-26-000053), on October 07, 2026, and is solely responsible for the information contained therein.
- Riley Exploration Permian drew USD 130 million under its Truist-led Credit Agreement on Oct. 5, 2026.
- Proceeds refinanced REP’s 10.50% Senior Unsecured Notes due 2028 via full voluntary prepayment of USD 130 million principal.
- Credit Agreement borrowings outstanding rose to USD 245 million; borrowing base USD 425 million; elected commitments USD 400 million.
- Facility pricing set at Term SOFR plus 2.75%-3.75% for SOFR loans; base rate plus 1.75%-2.75% for base-rate loans.
- Credit Agreement maturity extended to Dec. 13, 2028 following the notes repayment.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
KS Industry holds extraordinary shareholder meeting, elects directors
KS Industry held an extraordinary shareholder meeting on Oct. 8, 2026. Shareholders passed resolutions to appoint Kim In-gyeom as an internal director. Approval was also secured to appoint Chen Yang as an internal director. Resolutions to appoint Kim Woo-joon, Cha Haeng-jeon as independent directors were adopted. The votes authorized these board appointments; the filing did not confirm the appointments have been implemented. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. KS Industry Co. Ltd. published the original content used to generate this news brief via DART, the regulatory disclosure system operated by the South Korea Financial Supervisory Service (FSS) (Ref. ID: 20261008900252), on October 08, 2026, and is solely responsible for the information contained therein.
Pfizer (PFE.US) Tukysa approved in the United States for first-line breast cancer treatment
Pfizer (PFE.US) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has approved its tyrosine kinase inhibitor, Tukysa (tucatinib), as part of a combination regimen for first-line maintenance treatment of a certain type of breast cancer.
Veteran Danny Deep from General Dynamics appointed as the next CEO
Singapore stock index drops over 2%
Crypto prices
More
